Home ›
Trademark Categories ›
Pharmaceuticals ›
2004 ›
NO ›
NOBELRONDO
Trademark search for:
NOBELRONDO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-10-11 — Application filed
2005-10-14 — Application filed
2006-04-01 — Assigned to examiner
2006-04-07 — Final disposition recorded
2006-04-10 — Final disposition recorded
2006-10-10 — Office action issued
2006-10-10 — Correspondence received in law office
2006-11-03 — Teas/email correspondence entered
2006-11-24 — Final disposition recorded
2006-11-27 — Final disposition recorded
2007-05-23 — Office action issued
2007-06-09 — Teas/email correspondence entered
2007-06-09 — Assigned to lie
2007-06-09 — Correspondence received in law office
2007-06-30 — Approved for pub - principal register
2007-07-03 — Law office publication review completed
2007-07-18 — Notice of publication
2007-08-07 — Published for opposition
2007-10-23 — Registered-principal register
2009-06-18 — Teas change of correspondence received
2013-12-06 — Attorney/dom.rep.revoked and/or appointed
2013-12-06 — Teas revoke/app/change addr of atty/dom rep received
2014-05-30 — Cancelled sec. 8 (6-yr)
2014-05-30 — Final status recorded
Owner Information
Nobel Biocare Services AG
Zürich-Flughafen CH
Nobel Biocare Services AG
Zürich-Flughafen CH
Nobel Biocare Services AG
Zürich-Flughafen CH
Correspondent
Susan M. Natland Knobbe, Martens, Olson & Bear, LLP 2040 Main Street, 14th Floor Irvine, CA 92614 UNITED STATES
Filing Details
Filing Date:
2005-10-11
Status Date:
2014-05-30
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.